Purchase Order 36C24424P0542

Award Date 6/29/24
Potential Completion Date 6/28/25
Potential Value $215K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lebanon, PA 17042, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of the radiopharmaceutical Xofigo (radium-223 dichloride) for prostate cancer treatment. The contract has a ceiling value of $170,415.00 and a period of performance through June 28, 2026. Cardinal Health 414, LLC is a major supplier of...
This is a $12,623.78 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 8 (VISN 8), a component of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of the radiopharmaceutical product XOFIGO, used in the treatment of prostate cancer. Cardinal Health 414 is a key provider of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to federal healthcare...
This is a $32,295.44 firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC for the delivery of XOFIGO RA 223, a radiopharmaceutical product, with a completion date of February 29, 2024. Cardinal Health 414, LLC is a subsidiary of the global healthcare company Cardinal Health, Inc. and has previously received numerous indefinite delivery contracts from the VA and other federal health agencies to provide a...
This firm fixed-price purchase order contract was awarded by the Veterans Integrated Service Network 4 (VISN 4), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $64,325.92 and is for the delivery of the radiopharmaceutical Xofigo (radium-223 dichloride) to support nuclear medicine and oncology services for the VA healthcare system. The contract has an ultimate completion date of...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $645,701.90 firm-fixed-price delivery order contract to Cardinal Health 414, LLC for the radiopharmaceutical product XOFIGO. This order is part of the company's existing multi-year indefinite delivery contracts valued up to $39.8 million to provide radiopharmaceuticals and related supplies to VA medical centers and networks nationwide. Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., is a major...
This is a $31,018.03 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the emergency supply of the radiopharmaceutical Xofigo (radium-223 dichloride) for prostate cancer treatment. Cardinal Health 414 is a subsidiary of the global healthcare services company Cardinal Health, Inc. and specializes in providing radiopharmaceuticals and related products to federal agencies, including the VA, Department of Defense, and National...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 4 (VISN 4), a regional network of the Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of XOFIGO (radium-223 dichloride), a radiopharmaceutical therapy used for the treatment of prostate cancer. The contract has a ceiling value of $416,924.99 and a period of performance through June 28, 2024. Cardinal Health...
This federal contract award, valued at $43,835.77, was issued by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the emergency delivery of the radiopharmaceutical product XOFIGO to treat three patients. Cardinal Health 414 is a major supplier of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to various federal healthcare...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order contract to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of the radiopharmaceutical product XOFIGO, with a potential value of $150,000.00. The contract has a completion date of June 1, 2024. Cardinal Health 414 has previously held multiple indefinite delivery contracts to provide radiopharmaceuticals, specialized pharmaceuticals, and...
This federal contract award, valued at $261,303.00, was issued by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the supply of the radiopharmaceutical product Xofigo (radium-223 dichloride). The contract is a firm fixed-price purchase order with an ultimate completion date of April 11, 2026. Cardinal Health 414, LLC is a subsidiary of the larger Cardinal Health, Inc., a global healthcare services company that...

This is a $215,099 firm-fixed-price purchase order awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 4 (VISN 4). The contract is for the delivery of the radiopharmaceutical drug XOFIGO (radium-223 dichloride) through June 2025. Cardinal Health 414 is a major supplier of radiopharmaceuticals and specialized pharmaceutical products to federal healthcare agencies like the VA, Department of Defense, and National Institutes of Health, holding several multi-year indefinite delivery vehicle (IDV) contracts valued up to $39.8 million to support nuclear medicine, oncology, and other patient care programs. This award does not have a set-aside designation.

Generated 6/14/24, 10:14 AM